TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CHRS

Coherus BioSciences Inc

Healthcare · Biotechnology

1.10$ -3.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CHRS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-2.92 -2.91 -6.03 -3.77 -2.45 0.39 1.85 -0.50 -3.11 -1.86 -0.18 -1.15
0.08 0.05 0.07 0.06 0.05 0.04 0.03 0.05 0.05 0.04 0.05 0.03
1.35 0.45 0.65 0.68 0.54 0.46 0.46 0.68 0.65 0.46 0.24 0.14
3.69 0.60 0.72 0.72 0.54 0.47 0.46 3.31 1.07 – – –
3.47 2.45 -3.80 -0.10 0.16 -1.56 -0.42 0.56 -1.02 -0.39 0.49 -0.05
0.35 0.17 0.16 0.09 0.01 0.18 0.09 0.02 0.03 0.00 0.00 0.00
-0.06 -0.19 -0.16 -0.08 -0.02 -0.17 -0.17 -1.83 -2.15 1.54 2.01 3.12
0.00 0.00 0.00 0.00 – 0.99 0.24 0.02 0.05 – – –
0.00 0.31 0.06 -0.01 0.06 -0.01 -0.01 -0.02 -0.05 -0.04 – –
12.22 2.69 2.39 1.37 1.12 1.00 2.66 -0.01 0.64 0.00 -1.95 -2.33
16.61 3.31 5.40 3.89 1.62 1.22 2.68 0.69 0.70 0.74 -1.63 -2.27
13.54 0.21 -0.79 0.04 -0.84 1.43 4.36 -1.64 -4.56 0.42 0.20 -0.31
-3.27 -3.08 -6.18 -3.86 -2.46 0.21 1.76 -0.51 -3.13 -1.86 -0.18 -1.15

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?